CONRAY 30 Drug Patent Profile
✉ Email this page to a colleague
When do Conray 30 patents expire, and what generic alternatives are available?
Conray 30 is a drug marketed by Liebel-flarsheim and is included in one NDA.
The generic ingredient in CONRAY 30 is iothalamate meglumine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate meglumine profile page.
Summary for CONRAY 30
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 19 |
Patent Applications: | 461 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CONRAY 30 at DailyMed |
US Patents and Regulatory Information for CONRAY 30
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liebel-flarsheim | CONRAY 30 | iothalamate meglumine | INJECTABLE;INJECTION | 016983-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |